DK1741714T3 - Heterocyklisk forbindelse og middel mod ondartet turmor, der indeholder denne som aktiv ingrediens - Google Patents
Heterocyklisk forbindelse og middel mod ondartet turmor, der indeholder denne som aktiv ingrediensInfo
- Publication number
- DK1741714T3 DK1741714T3 DK05727794.9T DK05727794T DK1741714T3 DK 1741714 T3 DK1741714 T3 DK 1741714T3 DK 05727794 T DK05727794 T DK 05727794T DK 1741714 T3 DK1741714 T3 DK 1741714T3
- Authority
- DK
- Denmark
- Prior art keywords
- turmeric
- malignant
- active ingredient
- agent containing
- heterocyclic compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004103273 | 2004-03-31 | ||
| PCT/JP2005/006111 WO2005095389A1 (ja) | 2004-03-31 | 2005-03-30 | 複素環式化合物及びそれを有効成分とする抗悪性腫瘍剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1741714T3 true DK1741714T3 (da) | 2013-04-15 |
Family
ID=35063701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05727794.9T DK1741714T3 (da) | 2004-03-31 | 2005-03-30 | Heterocyklisk forbindelse og middel mod ondartet turmor, der indeholder denne som aktiv ingrediens |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7855199B2 (da) |
| EP (1) | EP1741714B1 (da) |
| JP (1) | JP4733021B2 (da) |
| KR (1) | KR101130913B1 (da) |
| CN (1) | CN100532380C (da) |
| AU (1) | AU2005227954B2 (da) |
| CA (1) | CA2561406C (da) |
| DK (1) | DK1741714T3 (da) |
| ES (1) | ES2400056T3 (da) |
| HK (1) | HK1105202A1 (da) |
| WO (1) | WO2005095389A1 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1310907C (zh) | 2001-04-27 | 2007-04-18 | 全药工业株式会社 | 杂环化合物和以其为有效成分的抗肿瘤药 |
| JP5089377B2 (ja) * | 2005-03-11 | 2012-12-05 | 全薬工業株式会社 | 複素環式化合物を有効成分とする免疫抑制剤及び抗腫瘍剤 |
| WO2008032077A1 (en) * | 2006-09-14 | 2008-03-20 | Astrazeneca Ab | Pyrimidine derivatives |
| DK2409975T3 (da) * | 2007-11-22 | 2015-08-03 | Zenyaku Kogyo Kk | Faste dispersioner omfattende et amorf legeme bestående af en heterocyklisk anti-tumor-forbindelse |
| WO2009120094A2 (en) * | 2008-03-27 | 2009-10-01 | Auckland Uniservices Limited | Substituted pyrimidines and triazines and their use in cancer therapy |
| EP2397479A4 (en) | 2009-02-12 | 2012-08-01 | Astellas Pharma Inc | HETERO RING DERIVATIVE |
| TW201038567A (en) | 2009-03-27 | 2010-11-01 | Pathway Therapeutics Ltd | Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| WO2011005119A1 (en) | 2009-07-07 | 2011-01-13 | Pathway Therapeutics Limited | Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| AU2011290189B8 (en) | 2010-08-10 | 2015-02-19 | Astellas Pharma Inc. | Heterocyclic compound |
| WO2012044641A1 (en) * | 2010-09-29 | 2012-04-05 | Pathway Therapeutics Inc. | 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| DK2691384T3 (da) | 2011-03-28 | 2017-01-16 | Mei Pharma Inc | (alpha-substitueret aralkylamino og heteroarylalkylamino) pyrimidinyl og 1,3,5-triazinyl benzimidazoler, farmaceutiske sammensætninger indeholdende dem, og disse forbindelser til anvendelse i behandling af proliferative sygdomme |
| CN105175410B (zh) * | 2015-10-14 | 2018-01-05 | 湖南华腾制药有限公司 | 三嗪类化合物及其制备方法和抗肿瘤应用 |
| CA3063976A1 (en) | 2017-05-23 | 2018-11-29 | Mei Pharma, Inc. | Combination therapy |
| MA49921A (fr) | 2017-08-14 | 2021-05-12 | Mei Pharma Inc | Polythérapie |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW312694B (da) | 1994-09-26 | 1997-08-11 | Daiichi Seiyaku Co | |
| KR100563514B1 (ko) * | 1997-07-24 | 2006-03-27 | 젠야쿠코교가부시키가이샤 | 헤테로고리 화합물 및 이를 유효성분으로 하는 항종양제 |
| CN1310907C (zh) * | 2001-04-27 | 2007-04-18 | 全药工业株式会社 | 杂环化合物和以其为有效成分的抗肿瘤药 |
| WO2004032930A1 (ja) | 2002-10-11 | 2004-04-22 | Kowa Co., Ltd. | 癌の処置方法 |
| ES2389253T3 (es) * | 2002-10-25 | 2012-10-24 | Zenyaku Kogyo Kabushiki Kaisha | Compuestos heterocíclicos y agentes antitumorales que comprenden los mismos como ingrediente activo |
-
2005
- 2005-03-30 CA CA2561406A patent/CA2561406C/en not_active Expired - Fee Related
- 2005-03-30 WO PCT/JP2005/006111 patent/WO2005095389A1/ja active Application Filing
- 2005-03-30 US US10/594,994 patent/US7855199B2/en not_active Expired - Fee Related
- 2005-03-30 AU AU2005227954A patent/AU2005227954B2/en not_active Ceased
- 2005-03-30 EP EP05727794A patent/EP1741714B1/en not_active Not-in-force
- 2005-03-30 JP JP2006511743A patent/JP4733021B2/ja not_active Expired - Fee Related
- 2005-03-30 ES ES05727794T patent/ES2400056T3/es active Active
- 2005-03-30 CN CNB2005800102150A patent/CN100532380C/zh not_active Expired - Fee Related
- 2005-03-30 KR KR1020067022675A patent/KR101130913B1/ko active IP Right Grant
- 2005-03-30 DK DK05727794.9T patent/DK1741714T3/da active
-
2007
- 2007-09-27 HK HK07110520.1A patent/HK1105202A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2561406A1 (en) | 2005-10-13 |
| CA2561406C (en) | 2012-07-03 |
| AU2005227954B2 (en) | 2011-02-10 |
| HK1105202A1 (en) | 2008-02-06 |
| KR101130913B1 (ko) | 2012-03-28 |
| EP1741714A4 (en) | 2007-09-12 |
| CN1972935A (zh) | 2007-05-30 |
| WO2005095389A1 (ja) | 2005-10-13 |
| US20080287431A1 (en) | 2008-11-20 |
| US7855199B2 (en) | 2010-12-21 |
| EP1741714B1 (en) | 2013-01-09 |
| JP4733021B2 (ja) | 2011-07-27 |
| EP1741714A1 (en) | 2007-01-10 |
| KR20070008670A (ko) | 2007-01-17 |
| AU2005227954A1 (en) | 2005-10-13 |
| ES2400056T3 (es) | 2013-04-05 |
| JPWO2005095389A1 (ja) | 2008-02-21 |
| CN100532380C (zh) | 2009-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1741714T3 (da) | Heterocyklisk forbindelse og middel mod ondartet turmor, der indeholder denne som aktiv ingrediens | |
| DK2279737T3 (da) | Heterocycliske forbindelser, der er aktive som beta-lactamaseinhibitorer | |
| NO20054244D0 (no) | Nitrogeninneholdende heterocykliske derivater og legemidler inneholdende de samme som den aktive bestanddel | |
| DK1864665T3 (da) | Immunsuppressivt middel indeholdende en heterocyklisk forbindelse som aktiv bestanddel | |
| NO20043702L (no) | 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
| NO20050665L (no) | Pyrrolidonderivater som MAOE inhibitoere | |
| NO20070046L (no) | Nytt cykloheksanderivat, prodrug derav og salt derav, og terapeutisk middel inneholdende de samme for diabetes | |
| DK1681932T3 (da) | Herbicidt aktivt middel | |
| DK1498411T3 (da) | Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel | |
| DK1817295T3 (da) | Triazolforbindelser, der modulerer HSP90-aktivitet | |
| NO20053775D0 (no) | Diazepinoindol derivater som kinaseinhibitorer. | |
| DK1557415T3 (da) | Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens | |
| DK1863812T3 (da) | Dipeptidylpeptidase-IV-inhiberende forbindelser, fremgangsmåder til fremstilling af de samme og farmaceutiske sammensætninger indeholdende de samme som aktive midler | |
| DK3311805T3 (da) | Sammensætninger, der omfatter svært vandopløselige farmaceutiske midler og antimikrobielle midler | |
| DK1797042T3 (da) | Indozolonderivater som 11B-HSD1-inhibitorer | |
| DK1603570T3 (da) | Aminoheteroarylforbindelser som proteinkinaseinhibitorer | |
| DK1690550T3 (da) | Terapeutisk middel til mesothelioma | |
| DK2114955T3 (da) | Broforbundet, bicyklisk aryl og broforbundet, bicyklisk heteroaryl subsitiuerede triazoler, der er anvendelige som axl-inhibitorer | |
| NO20053215D0 (no) | Pyrazolderivater med anvendelse som COX-1-inhibitorer. | |
| DK1564210T3 (da) | 4-Oxoquinolinforbindelser og anvendelse deraf som HIV-integraseinhibitorer | |
| DK2039685T3 (da) | Heterobicycliske forbindelser som P38-inhibitorer | |
| BRPI0608885A2 (pt) | composto de isômero c de sdz-rad, composição farmacêutica, e, embalagem farmacêutica | |
| ITBO20030081A1 (it) | Pacchetto di sigarette. | |
| DK1932522T3 (da) | Terapeutisk middel mod leversygdom indeholdende 2-amino-1,3-propandiolderivat som aktiv bestanddel | |
| NO20081160L (no) | Benzimidazoltiofen forbindelser |